27 March 2024
27 March 2024
The Italian Medicines Agency (AIFA) and the French Medicines Agency (ANSM) have granted approval for the clinical trial application.
Auxilius Pharma has developed AUX-001 which is a once-daily version of nicorandil for patients with chronic stable angina pectoris.
CROs are fundamental to the development of cancer treatments but face multiple challenges. We analyze the biggest trends in oncology and the technological solutions available to CROs to optimize efficiencies.
Implantica has submitted the first module of the PMA application for RefluxStop, with subsequent modules planned for submission in the next six months.
The AI-QCT ISCHEMIA software uses AI to analyse atherosclerosis and blood vessel shapes from CCTA images.
The company anticipates reporting topline findings from the trial in the first half of next year.
VK2735 was safe and well-tolerated in the trial, with all TEAEs observed to be mild or moderate in nature.
In the trial, mRNA-1283 elicited a higher immune response against the SARS-CoV-2 virus, compared to mRNA-1273.222.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
